Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Blood and Tissue Eosinophils in the Fibrogenesis of Systemic Sclerosis

NCT03816189 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03816189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03816189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Blood and Tissue Eosinophils in the Fibrogenesis of Systemic Sclerosis
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
October 3, 2018
Completion date
April 5, 2022
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic scleroderma, systemic sclerosis